AA
AGN

AQR Arbitrage’s Allergan plc AGN Stock Holding History

AQR Arbitrage’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-365,933
Closed -$64.8M – 618
2020
Q1 		$64.8M Sell
365,933
-420,790
-53% -$79.2M 2.17% 3
2019
Q4 		$150M Sell
786,723
-139,373
-15% -$25.1M 2.54% 4
2019
Q3 		$156M Buy
926,096
+30,096
+3% +$4.9M 2.28% 8
2019
Q2 		$150M Buy
+896,000
New +$124M 1.71% 15
2016
Q2 		– Sell
-124,941
Closed -$33.5M – 439
2016
Q1 		$33.5M Sell
124,941
-198,801
-61% -$56.9M 0.39% 66
2015
Q4 		$101M Buy
+323,742
New +$96.4M 1.13% 22

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AQR Arbitrage's AGN Position: Q2 2020 in Review

AQR Arbitrage sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 365,933 shares — an estimated $64.8M sold.

AQR Arbitrage first reported a position in AGN in Q4 2015 and held it in 6 quarters. The position peaked at $156M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AQR Arbitrage reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AQR Arbitrage sold 365,933 Allergan plc shares in Q2 2020, an estimated $64.8M.
  • AQR Arbitrage first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
  • AQR Arbitrage's Allergan plc position peaked at $156M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AQR Arbitrage's 13F filing for Q2 2020, filed 17 Aug 2020.